Human papillomavirus genotyping by Linear Array and Next-Generation Sequencing in cervical samples from Western Mexico

Virology Journal

Volumn 12, Issue 1, 2015, Pages

  Flores Miramontes, María Guadalupe ^a,b   Torres Reyes, Luis Alberto ^a,b   Alvarado Ruíz, Liliana ^a,b   Romero Martínez, Salvador Angel ^c   Ramírez Rodríguez, Verenice ^c   Balderas Peña, Luz María Adriana ^d   Vallejo Ruíz, Verónica ^a   Piña Sánchez, Patricia ^a   Cortés Gutiérrez, Elva Irene ^a   Jave Suárez, Luis Felipe ^a   Aguilar Lemarroy, Adriana ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b UNIVERSITY OF GUADALAJARA   (Mexico)

^c Diagnostics Division   (Mexico)

^d HOSPITAL DE ESPECIALIDADES   (Mexico)

Author keywords

454 Next Generation Sequencing; HPV genotyping; Human papillomavirus; Linear Array; Mexican women; PGMY09 11

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER RISK; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DNA EXTRACTION; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; HUMAN PAPILLOMAVIRUS TYPE 102; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 114; HUMAN PAPILLOMAVIRUS TYPE 26; HUMAN PAPILLOMAVIRUS TYPE 32; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 44; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN PAPILLOMAVIRUS TYPE 68; HUMAN PAPILLOMAVIRUS TYPE 73; HUMAN PAPILLOMAVIRUS TYPE 74; HUMAN PAPILLOMAVIRUS TYPE 89; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MEXICAN; NEXT GENERATION SEQUENCING; NONHUMAN; POLYMERASE CHAIN REACTION; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VIRUS DETECTION; WART VIRUS; CLASSIFICATION; GENETICS; GENOTYPE; GENOTYPING TECHNIQUE; HIGH THROUGHPUT SEQUENCING; ISOLATION AND PURIFICATION; MEXICO; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; PROCEDURES; UTERINE CERVIX; VIROLOGY;

ADULT; AGED; CERVIX UTERI; FEMALE; GENOTYPE; GENOTYPING TECHNIQUES; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MEXICO; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE;

EID: 84943581821     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/s12985-015-0391-4     Document Type: Article

References (48)

1. Globocan. Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012 IARC. 2012. http://globocan.iarc.fr/Default.aspx. Accessed 05-13-2015 2015.
2. Zur Hausen H. Papillomavirus infections - a major cause of human cancers. Biochim Biophys Acta. 1996;1288(2):F55-78.
3. HPVCenter. International Human Papillomavirus Reference Center. Davit Bzhalava, Karolinska Institutet. http://www.hpvcenter.se/html/refclones.html. Accessed February 11 2015.
4. Bosch FX, Manos MM, Muñoz N, Sherman M, Jansen AM, Peto J, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst. 1995;87(11):796-802.
5. Clifford G, Smith J, Plummer M, Munoz N, Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer. 2003;88(1):63-73.
6. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, et al. A review of human carcinogens - Part B: biological agents. Lancet Oncol. 2009;10(4):321-2.
7. de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010;11(11):1048-56. doi: 10.1016/S1470-2045(10)70230-8.
8. Guan P, Howell-Jones R, Li N, Bruni L, de Sanjose S, Franceschi S, et al. Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer. Int J Cancer. 2012;131(10):2349-59. doi: 10.1002/ijc.27485.
9. Tjalma WA, Fiander A, Reich O, Powell N, Nowakowski AM, Kirschner B, et al. Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe. Int J Cancer. 2013;132(4):854-67. doi: 10.1002/ijc.27713.
10. Froberg M, Johansson B, Hjerpe A, Andersson S. Human papillomavirus 'reflex' testing as a screening method in cases of minor cytological abnormalities. Br J Cancer. 2008;99(4):563-8. doi: 10.1038/sj.bjc.6604504.
11. Ferreccio C, Corvalan A, Margozzini P, Viviani P, Gonzalez C, Aguilera X, et al. Baseline assessment of prevalence and geographical distribution of HPV types in Chile using self-collected vaginal samples. BMC Public Health. 2008;8:78. doi: 10.1186/1471-2458-8-78.
12. Wong OG, Lo CK, Chow JN, Tsun OK, Szeto E, Liu SS, et al. Comparison of the GenoFlow human papillomavirus (HPV) test and the Linear Array assay for HPV screening in an Asian population. J Clin Microbiol. 2012;50(5):1691-7. doi: 10.1128/JCM.05933-11.
13. Schmidt-Grimminger DC, Bell MC, Muller CJ, Maher DM, Chauhan SC, Buchwald DS. HPV infection among rural American Indian women and urban white women in South Dakota: an HPV prevalence study. BMC Infect Dis. 2011;11:252. doi: 10.1186/1471-2334-11-252.
14. Aguilar-Lemarroy A, Vallejo-Ruiz V, Cortes-Gutierrez EI, Salgado-Bernabe ME, Ramos-Gonzalez NP, Ortega-Cervantes L, et al. Human papillomavirus infections in Mexican women with normal cytology, precancerous lesions, and cervical cancer: type-specific prevalence and HPV coinfections. J Med Virol. 2015;87(5):871-84. doi: 10.1002/jmv.24099.
15. Poljak M, Kocjan BJ. Commercially available assays for multiplex detection of alpha human papillomaviruses. Expert Rev Anti Infect Ther. 2010;8(10):1139-62. doi: 10.1586/eri.10.104.
16. Barzon L, Militello V, Lavezzo E, Franchin E, Peta E, Squarzon L, et al. Human papillomavirus genotyping by 454 next generation sequencing technology. J Clin Virol. 2011;52(2):93-7. doi: 10.1016/j.jcv.2011.07.006.
17. Arroyo LS, Smelov V, Bzhalava D, Eklund C, Hultin E, Dillner J. Next generation sequencing for human papillomavirus genotyping. J Clin Virol. 2013;58(2):437-42. doi: 10.1016/j.jcv.2013.07.013.
18. Militello V, Lavezzo E, Costanzi G, Franchin E, Di Camillo B, Toppo S, et al. Accurate human papillomavirus genotyping by 454 pyrosequencing. Clin Microbiol Infect. 2013;19(10):E428-34. doi: 10.1111/1469-0691.12219.
19. Schiffman M, Wentzensen N, Wacholder S, Kinney W, Gage JC, Castle PE. Human papillomavirus testing in the prevention of cervical cancer. J Natl Cancer Inst. 2011;103(5):368-83.
20. Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer. 2007;121(3):621-32. doi: 10.1002/ijc.22527.
21. Anderson L, O'Rorke M, Jamison J, Wilson R, Gavin A. members HPVWG. Prevalence of human papillomavirus in women attending cervical screening in the UK and Ireland: new data from northern Ireland and a systematic review and meta-analysis. J Med Virol. 2013;85(2):295-308. doi: 10.1002/jmv.23459.
22. Quek SC, Lim BK, Domingo E, Soon R, Park JS, Vu TN, et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical intraepithelial neoplasia across 5 countries in Asia. Int J Gynecol Cancer. 2013;23(1):148-56. doi: 10.1097/IGC.0b013e31827670fd.
23. Beaudenon S, Praetorius F, Kremsdorf D, Lutzner M, Worsaae N, Pehau-Arnaudet G, et al. A new type of human papillomavirus associated with oral focal epithelial hyperplasia. J Invest Dermatol. 1987;88(2):130-5.
24. Falaki F, Amir Chaghmaghi M, Pakfetrat A, Delavarian Z, Mozaffari PM, Pazooki N. Detection of human papilloma virus DNA in seven cases of focal epithelial hyperplasia in Iran. J Oral Pathol Med. 2009;38(10):773-6. doi: 10.1111/j.1600-0714.2009.00784.x.
25. Volter C, He Y, Delius H, Roy-Burman A, Greenspan JS, Greenspan D, et al. Novel HPV types present in oral papillomatous lesions from patients with HIV infection. Int J Cancer. 1996;66(4):453-6. doi: 10.1002/(SICI)1097-0215(19960516)66:4<453::AID-IJC7>3.0.CO;2-V.
26. Kim NR, Kang M, Lee SP, Kim H, An J, Chung DH, et al. Uncommon and rare human papillomavirus genotypes relating to cervical carcinomas. Korean journal of pathology. 2014;48(1):43-9. doi: 10.4132/KoreanJPathol.2014.48.1.43.
27. Caldeira S, Dong W, Tomakidi P, Paradiso A, Tommasino M. Human papillomavirus type 32 does not display in vitro transforming properties. Virology. 2002;301(1):157-64.
28. Lorincz AT, Quinn AP, Goldsborough MD, Schmidt BJ, Temple GF. Cloning and partial DNA sequencing of two new human papillomavirus types associated with condylomas and low-grade cervical neoplasia. J Virol. 1989;63(6):2829-34.
29. Denny L, Adewole I, Anorlu R, Dreyer G, Moodley M, Smith T, et al. Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub-Saharan Africa. Int J Cancer. 2014;134(6):1389-98.
30. Guimera N, Lloveras B, Lindeman J, Alemany L, van de Sandt M, Alejo M, et al. The occasional role of low-risk human papillomaviruses 6, 11, 42, 44, and 70 in anogenital carcinoma defined by laser capture microdissection/PCR methodology: results from a global study. Am J Surg Pathol. 2013;37(9):1299-310. doi: 10.1097/PAS.0b013e31828b6be4.
31. Sandri MT, Riggio D, Salvatici M, Passerini R, Zorzino L, Boveri S, et al. Typing of human papillomavirus in women with cervical lesions: prevalence and distribution of different genotypes. J Med Virol. 2009;81(2):271-7. doi: 10.1002/jmv.21382.
32. Stevens MP, Garland SM, Tan JH, Quinn MA, Petersen RW, Tabrizi SN. HPV genotype prevalence in women with abnormal pap smears in Melbourne, Australia. J Med Virol. 2009;81(7):1283-91. doi: 10.1002/jmv.21515.
33. Nielsen A, Iftner T, Norgaard M, Munk C, Junge J, Kjaer SK. The importance of low-risk HPV infection for the risk of abnormal cervical cytology/histology in more than 40 000 Danish women. Sex Transm Infect. 2012;88(8):627-32. doi: 10.1136/sextrans-2011-050307.
34. Petry KU, Luyten A, Justus A, Iftner A, Strehlke S, Schulze-Rath R, et al. Prevalence of low-risk HPV types and genital warts in women born 1988/89 or 1983/84 -results of WOLVES, a population-based epidemiological study in Wolfsburg, Germany. BMC infectious diseases. 2012;12:367. doi: 10.1186/1471-2334-12-367.
35. Longuet M, Cassonnet P, Orth G. A novel genital human papillomavirus (HPV), HPV type 74, found in immunosuppressed patients. J Clin Microbiol. 1996;34(7):1859-62.
36. de Villiers EM. Cross-roads in the classification of papillomaviruses. Virology. 2013;445(1-2):2-10. doi: 10.1016/j.virol.2013.04.023.
37. Giuliano AR, Lazcano-Ponce E, Villa LL, Flores R, Salmeron J, Lee JH, et al. The human papillomavirus infection in men study: human papillomavirus prevalence and type distribution among men residing in Brazil, Mexico, and the United States. Cancer Epidemiol Biomarkers Prev. 2008;17(8):2036-43. doi: 10.1158/1055-9965.EPI-08-0151.
38. Meiring TL, Salimo AT, Coetzee B, Maree HJ, Moodley J, Hitzeroth II, et al. Next-generation sequencing of cervical DNA detects human papillomavirus types not detected by commercial kits. Virol J. 2012;9:164. doi: 10.1186/1743-422X-9-164.
39. Chen Z, Schiffman M, Herrero R, Burk RD. Identification and characterization of two novel human papillomaviruses (HPVs) by overlapping PCR: HPV102 and HPV106. J Gen Virol. 2007;88(Pt 11):2952-5. doi: 10.1099/vir.0.83178-0.
40. Ekstrom J, Forslund O, Dillner J. Three novel papillomaviruses (HPV109, HPV112 and HPV114) and their presence in cutaneous and mucosal samples. Virology. 2010;397(2):331-6. doi: 10.1016/j.virol.2009.11.027.
41. de Sanjose S, Alemany L, Ordi J, Tous S, Alejo M, Bigby SM, et al. Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva. Eur J Cancer. 2013;49(16):3450-61. doi: 10.1016/j.ejca.2013.06.033.
42. Bernard HU. Coevolution of papillomaviruses with human populations. Trends Microbiol. 1994;2(4):140-3.
43. De Villiers EM, Fauquet C, Broker TR, Bernard HU, Zur Hausen H. Classification of papillomaviruses. Virology. 2004;324(1):17-27. doi: 10.1016/j.virol.2004.03.033.
44. IARC. International Agency for Research on Cancer. http://www.iarc.fr/en/about/index.php. 2015. Accessed May 2015.
45. Lichtig H, Algrisi M, Botzer LE, Abadi T, Verbitzky Y, Jackman A, et al. HPV16 E6 natural variants exhibit different activities in functional assays relevant to the carcinogenic potential of E6. Virology. 2006;350(1):216-27. doi: 10.1016/j.virol.2006.01.038.
46. Gravitt PE, Peyton CL, Alessi TQ, Wheeler CM, Coutlee F, Hildesheim A, et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol. 2000;38(1):357-61.
47. Coutlee F, Rouleau D, Petignat P, Ghattas G, Kornegay JR, Schlag P, et al. Enhanced detection and typing of human papillomavirus (HPV) DNA in anogenital samples with PGMY primers and the Linear array HPV genotyping test. J Clin Microbiol. 2006;44(6):1998-2006. doi: 10.1128/JCM.00104-06.
48. PAVE. Papillomavirus Episteme. National Institute of Allergy and Infectious Diseases and National Institutes of Health. 2015. http://pave.niaid.nih.gov/. 2015.